Diabetic retinopathy clinical practice guidelines: Customized for Iranian population

Rajavi, Z. and Safi, S. and Javadi, M. and Azarmina, M. and Moradian, S. and Entezari, M. and Nourinia, R. and Ahmadieh, H. and Shirvani, A. and Shahraz, S. and Ramezani, A. and Dehghan, M. and Shahsavari, M. and Soheilian, M. and Nikkhah, H. and Ziaei, H. and Behboudi, H. and Farrahi, F. and Falavarjani, K. and Parvaresh, M. and Fesharaki, H. and Abrishami, M. and Shoeibi, N. and Rahimi, M. and Javadzadeh, A. and Karkhaneh, R. and Riazi-Esfahani, M. and Manaviat, M. and Maleki, A. and Kheiri, B. and Golbafian, F. (2016) Diabetic retinopathy clinical practice guidelines: Customized for Iranian population. Journal of Ophthalmic and Vision Research, 11 (4). pp. 394-414.

[img] Text
JOVR-11-394.pdf

Download (492kB)

Abstract

Purpose: To customize clinical practice guidelines (CPGs) for management of diabetic retinopathy (DR) in the Iranian population. Methods: Three DR CPGs (The Royal College of Ophthalmologists 2013, American Academy of Ophthalmology Preferred Practice Pattern 2012, and Australian Diabetes Society 2008) were selected from the literature using the AGREE tool. Clinical questions were designed and summarized into four tables by the customization team. The components of the clinical questions along with pertinent recommendations extracted from the above-mentioned CPGs; details of the supporting articles and their levels of evidence; clinical recommendations considering clinical benefts, cost and side effects; and revised recommendations based on customization capability (applicability, acceptability, external validity) were recorded in 4 tables, respectively. Customized recommendations were sent to the faculty members of all universities across the country to score the recommendations from 1 to 9. Results: Agreed recommendations were accepted as the fnal recommendations while the non-agreed ones were approved after revision. Eventually, 29 customized recommendations under three major categories consisting of screening, diagnosis and treatment of DR were developed along with their sources and levels of evidence. Conclusion: This customized CPGs for management of DR can be used to standardize the referral pathway, diagnosis and treatment of patients with diabetic retinopathy. © 2016 Journal of Ophthalmic and Vision Research.

Item Type: Article
Additional Information: Cited By :5 Export Date: 16 February 2020 Correspondence Address: Safi, S.; Knowledge Management Unit, Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, No 23, Paidarfard St., Boostan 9 St. Pasdaran Ave., Iran; email: sare.saf@yahoo.com
Uncontrolled Keywords: Clinical Practice Guidelines Diabetic Retinopathy Iran
Subjects: WK Endocrine System
Divisions: Mashhad University of Medical Sciences
Depositing User: mr lib4 lib4
Date Deposited: 29 Feb 2020 11:05
Last Modified: 29 Feb 2020 11:05
URI: http://eprints.mums.ac.ir/id/eprint/13156

Actions (login required)

View Item View Item